9 months follow up from my original post and part 2: https://www.reddit.com/r/wallstreetbets/comments/1tgmcba/moderna_generational_yolo_territory_part_2/ TLDR: The stock is going to 300. First i want to say thank you to everyone that messaged me there are 551 unread messages right now. I think i laid out the case and targets pretty well in my previous posts. Short interest is still high so one can only assume that the Wednesday pump was a gamma squeeze instead of short. Meaning that a bigger pump is coming. Even after all the pumping the market cap is STILL small and undervalued. 60 billion as of right this. My initialize estimates were based on Keytruda's revenue which is 20 billion/yr. Even with the profit sharing agreement with merck moderna is still undervalued by at least 50%. The stock should maintain a level closer to $250. Finally, long term using intersimeran on a patient resolves one cancer and if that person lives on instead of usual death there is a chance that person catches another type of cancer because whatever environmental carcinogen is present in their life goes undetected so intersimeran should create more revenue than keytruda. Effectively the company is primed to grow well into the 250 billion dollar cancer market. Position: 16k shares @ 27.5 profit: 2.4M cashed out.   submitted by   /u/VoidAndOcean [link]   [comments]